AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 86 filers reported holding AVADEL PHARMACEUTICALS PLC in Q1 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $247,200 | -37.5% | 24,000 | 0.0% | 0.00% | -40.0% |
| Q2 2023 | $395,520 | +100.8% | 24,000 | +11.6% | 0.01% | +150.0% |
| Q1 2023 | $196,940 | +120.0% | 21,500 | +72.0% | 0.00% | +100.0% |
| Q4 2022 | $89,500 | +31.6% | 12,500 | -7.4% | 0.00% | 0.0% |
| Q3 2022 | $68,000 | +106.1% | 13,500 | 0.0% | 0.00% | – |
| Q2 2022 | $33,000 | -65.6% | 13,500 | -3.6% | 0.00% | -100.0% |
| Q1 2022 | $96,000 | -52.5% | 14,000 | -44.0% | 0.00% | -66.7% |
| Q4 2021 | $202,000 | -18.5% | 25,000 | 0.0% | 0.00% | -25.0% |
| Q3 2021 | $248,000 | +61.0% | 25,000 | +8.7% | 0.00% | +33.3% |
| Q2 2021 | $154,000 | -13.0% | 23,000 | +17.9% | 0.00% | -25.0% |
| Q1 2021 | $177,000 | – | 19,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 1,625,000 | $12,269,000 | 3.04% |
| GENDELL JEFFREY L | 1,146,764 | $8,658,000 | 1.11% |
| Broadfin Capital, LLC | 1,029,012 | $7,769,000 | 1.04% |
| RTW INVESTMENTS, LP | 3,401,434 | $25,681,000 | 0.97% |
| BRANDES INVESTMENT PARTNERS, LP | 3,651,948 | $27,571,000 | 0.66% |
| Aristides Capital LLC | 71,520 | $540,000 | 0.42% |
| Tekla Capital Management LLC | 814,588 | $6,150,000 | 0.23% |
| INVESTORS ASSET MANAGEMENT OF GEORGIA INC /GA/ /ADV | 36,100 | $273,000 | 0.17% |
| Leap Investments LP | 43,481 | $328,000 | 0.15% |
| Brown Capital Management | 1,829,886 | $13,816,000 | 0.13% |